Literature DB >> 28222663

miR-29a suppresses MCF-7 cell growth by downregulating tumor necrosis factor receptor 1.

Yiling Zhao1, Fenghua Yang2, Wenyuan Li3, Chunyan Xu4, Li Li3, Lifei Chen5, Yancui Liu3, Ping Sun3.   

Abstract

Tumor necrosis factor receptor 1 is the main receptor mediating many tumor necrosis factor-alpha-induced cellular events. Some studies have shown that tumor necrosis factor receptor 1 promotes tumorigenesis by activating nuclear factor-kappa B signaling pathway, while other studies have confirmed that tumor necrosis factor receptor 1 plays an inhibitory role in tumors growth by inducing apoptosis in breast cancer. Therefore, the function of tumor necrosis factor receptor 1 in breast cancer requires clarification. In this study, we first found that tumor necrosis factor receptor 1 was significantly increased in human breast cancer tissues and cell lines, and knockdown of tumor necrosis factor receptor 1 by small interfering RNA inhibited cell proliferation by arresting the cell cycle and inducing apoptosis. In addition, miR-29a was predicted as a regulator of tumor necrosis factor receptor 1 by TargetScan and was shown to be inversely correlated with tumor necrosis factor receptor 1 expression in human breast cancer tissues and cell lines. Luciferase reporter assay further confirmed that miR-29a negatively regulated tumor necrosis factor receptor 1 expression by binding to the 3' untranslated region. In our functional study, miR-29a overexpression remarkably suppressed cell proliferation and colony formation, arrested the cell cycle, and induced apoptosis in MCF-7 cell. Furthermore, in combination with tumor necrosis factor receptor 1 transfection, miR-29a significantly reversed the oncogenic role caused by tumor necrosis factor receptor 1 in MCF-7 cell. In addition, we demonstrated that miR-29a suppressed MCF-7 cell growth by inactivating the nuclear factor-kappa B signaling pathway and by decreasing cyclinD1 and Bcl-2/Bax protein levels. Taken together, our results suggest that miR-29a is an important regulator of tumor necrosis factor receptor 1 expression in breast cancer and functions as a tumor suppressor by targeting tumor necrosis factor receptor 1 to influence the growth of MCF-7 cell.

Entities:  

Keywords:  MCF-7 cell; Tumor necrosis factor receptor 1; miR-29a

Mesh:

Substances:

Year:  2017        PMID: 28222663     DOI: 10.1177/1010428317692264

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  10 in total

1.  Klotho Ameliorates Cellular Inflammation via Suppression of Cytokine Release and Upregulation of miR-29a in the PBMCs of Diagnosed Alzheimer's Disease Patients.

Authors:  Mohsen Sedighi; Tourandokht Baluchnejadmojarad; Soudabeh Fallah; Nariman Moradi; Siamak Afshin-Majdd; Mehrdad Roghani
Journal:  J Mol Neurosci       Date:  2019-06-13       Impact factor: 3.444

2.  3,3'-Diindolylmethane Encapsulated Chitosan Nanoparticles Accelerates Inflammatory Markers, ER/PR, Glycoprotein and Mast Cells Population During Chemical Carcinogen Induced Mammary Cancer in Rats.

Authors:  Stainsloss Isabella; Sankaran Mirunalini; Kannaiyan Pandiyan
Journal:  Indian J Clin Biochem       Date:  2017-09-23

3.  Cuproptosis-related gene SLC31A1 is a potential predictor for diagnosis, prognosis and therapeutic response of breast cancer.

Authors:  Xiao Li; Zhaosheng Ma; Linhang Mei
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

4.  The Cytotoxic and Anti-Migratory Properties of Caesalpinia sappan and Ficus septica, in Combination with Doxorubicin on 4T1 TNBC Cells with Nephroprotective Potential.

Authors:  Sari Haryanti; Ummi Maryam Zulfin; Irfani Aura Salsabila; Febri Wulandari; Edy Meiyanto
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01

Review 5.  Preclinical and clinical aspects of TNF-α and its receptors TNFR1 and TNFR2 in breast cancer.

Authors:  Isela Martínez-Reza; Lorenza Díaz; Rocío García-Becerra
Journal:  J Biomed Sci       Date:  2017-12-04       Impact factor: 8.410

6.  MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer.

Authors:  Xin Liu; Xianping Lv; Qiankun Yang; Huifang Jin; Wenpeng Zhou; Qingxia Fan
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

7.  Clinical significance of tumor necrosis factor receptor 2 in middle and lower thoracic esophageal squamous cell carcinoma.

Authors:  Dong Yang; Ruidong Li; Huili Wang; Junye Wang; Ye Li; Hongbo Wang; Wei Wang; Zifeng Liu
Journal:  Oncol Lett       Date:  2018-06-20       Impact factor: 2.967

8.  A Comprehensive Analysis for Expression, Diagnosis, and Prognosis of m5C Regulator in Breast Cancer and Its ncRNA-mRNA Regulatory Mechanism.

Authors:  Jingxing Liu; Shuyuan Xiao; Jing Chen; Weiyang Lou; Xu Chen
Journal:  Front Genet       Date:  2022-06-22       Impact factor: 4.772

Review 9.  MiR-29a: a potential therapeutic target and promising biomarker in tumors.

Authors:  Jin-Yan Wang; Qian Zhang; Dan-Dan Wang; Wei Yan; Huan-Huan Sha; Jian-Hua Zhao; Su-Jin Yang; He-da Zhang; Jun-Chen Hou; Han-Zi Xu; Yun-Jie He; Jia-Hua Hu; Shan-Liang Zhong; Jin-Hai Tang
Journal:  Biosci Rep       Date:  2018-02-08       Impact factor: 3.840

10.  Downregulation of Cohesin Loading Factor Nipped-B-Like Protein (NIPBL) Induces Cell Cycle Arrest, Apoptosis, and Autophagy of Breast Cancer Cell Lines.

Authors:  Huanhuan Zhou; Lei Zheng; Kongbeng Lu; Yun Gao; Liwei Guo; Weizhen Xu; Xiaojia Wang
Journal:  Med Sci Monit       Date:  2017-10-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.